ÌÇÐÄÆƽâ°æ

In 2025, the number of GSK (GlaxoSmithKline) employees in Europe totaled about *. The number of employees in Europe stood at a record-high of almost * in 2015, but dropped since then back to *.

GlaxoSmithKline’s pharmaceuticals

GlaxoSmithKline is a global pharmaceutical manufacturer and developer that creates medicines and vaccinations. In 2024, GlaxoSmithKline was among the global top ten pharmaceutical companies based on pharmaceutical sales. GlaxoSmithKline has many kinds of pharmaceuticals available, and they excel in certain therapeutic areas, such as respiratory pharmaceuticals. Advair, a respiratory pharmaceutical product marketed by GlaxoSmithKline, is a long-time best-selling respiratory medication. 

GlasxoSmithKline’s global revenue

From 2006 to 2024, GSK’s revenues generally saw some ups and downs, with lower revenues in more recent years mostly due to the spin-off of its consumer healthcare segment in 2022. As of now, pharmaceuticals and vaccines are the core generators of the company’s yearly revenues. GSK’s revenues are regionally variable. The United States accounts for the largest proportion of the company’s revenues.